Yuyuan Co., Ltd.: It is planned to grant 110.19 million shares to the incentive object of 140 people

Every time AI News, Yuyuan Co., Ltd. (SH 600655, closing price: 6.87 yuan) issued an announcement on the evening of September 27 that a total of 140 incentive objects were granted by this incentive plan. For the company's ordinary shares of the company that is directed to the incentive object; the total number of equity incentives and the total number of target shares involved: the number of restricted shares granted to the incentive object of this plan is not more than 11.019 million shares. The total amount of the company's share capital on this plan was 0.283%of the total share capital of 3.891 billion shares; the grant price of the awarded restricted stock was 3.82 yuan/share, that is, after meeting the grant conditions, the incentive target could purchase a price of 3.82 yuan per share to purchase the company to add to the incentive object. When the company's stock, the validity period of self -restricted stocks from the date from the date of granting of the stock to the restrictions granted by the incentive target will be lifted up to 48 months.

From January to June 2022, the operating income of Yuyuan Co., Ltd. was composed of: 71.04%of gold jewelry, 12.96%of property development and sales, 5.58%of the wine industry, 2.25%of handicrafts and department stores and services, and business accounted for business accounts for 2.25%. Compared with 2.04%.

The chairman of Yuyuan Co., Ltd. is Huang Zhen, male, 51 years old, and his academic background is a master's degree.

As of press time, the market value of Yuyuan's shares was 26.7 billion yuan.

Daeda1997 "Single Stock Trends" reminder:

1. Yuyuan shares have increased by 8.021 million shares in the northern direction in the past 30 days, an increase of 0.21%of the proportion of circulating shares;

2. In the past 30 days, there was no correction to investigate the shares of Yuyuan.

For more stock trend information, please search for the WeChat public account "Daida", reply "Query", and receive free query permissions!

Each headline (NBDTOUTIAO) — Li Xiaoyi, chairman of the board of directors of Zhaofe Ophthalmology: The most important thing at the moment is to get the Atto "admission ticket", the new drug company must survive first

(Reporter Wang Xiaobo)

Disclaimer: The content and data of this article are for reference only, and do not constitute investment suggestions. Please verify before use. Based on this, the risk is on its own.

Daily Economic News

- END -